Dietary management drugs have transformed Type 2 diabetes care, but daily injection routines are challenging for some patients. A new hydrogel could mean shots just three times a year.

In this episode, chemist Jonathan Z. Long discusses his recent discovery of a new molecule produced when we exercise that appears to be linked to health benefits from regulating appetite to boosting learning and memory.

The story of neonatal diabetes continues as we hear about the remarkable science that led  to  the genetic diagnosis and new treatment that transformed  Jack’s life in episode 1.  In this episode Maggie and Andrew talk to Anna Gloyn, the  scientist who discovered the gene that was usually altered when very young babies are  diagnosed with neonatal diabetes.

Drs. Ananta Addala, Danny Chou, Anna Gloyn and Rayhan Lal spoke to The SugarScience on flexing innovations in genetics, insulin bioengineering, and diabetes technology to advance health equity in diabetes diagnosis and management.

Diabetes can show up in almost anyone: pregnant women, babies, kids, teens, adults both young and old.

But the condition's various forms, all of which affect how the body processes blood sugar, can manifest quite differently in the hundreds of millions of people worldwide who have the disease -- making it perfect for the individualized approach known as precision medicine, Stanford Medicine researchers say.